|
|
|
|
|
by silencio
4196 days ago
|
|
Problematic generics seem to come up often about extended release formulations when hanging around ADHD communities. Judging from this latest one I remember, it takes a big push for the FDA to start looking into it and ask questions: http://www.fda.gov/Drugs/DrugSafety/ucm422568.htm As consumers, we don't really have much of a way to test for placebo effects or when generics are actually subpar other than complaining until someone listens... so... it's a bit of a chicken/egg problem. |
|